# Cartography Biosciences

> Oncology biotech building an antigen atlas for precise antibody immunotherapies.

## Why it is interesting

Maps tumor-specific antigens systematically — 8VC-led Series A with a16z seed continuity into Pfizer Ventures-led Series B.

## Profile

- **Stage:** series-b
- **Status:** private
- **Industries:** healthtech, biotech-life-sciences
- **Coverage:** full
- **Last updated:** 2026-07-24

## Key facts

- Series B (2025): $67M led by Pfizer Ventures; 8VC, Gaingels, a16z among existing investors (BusinessWire)
- Series A (2022): $57M led by 8VC; a16z (seed lead) and Wing participated (a16z announcement)

## Investors in our directory

- https://venturecapitaltracker.com/fund/andreessen-horowitz
- https://venturecapitaltracker.com/fund/8vc
- https://venturecapitaltracker.com/fund/gaingels

---
Source: https://venturecapitaltracker.com/startup/cartography-biosciences